Influence of Prostate Cancer on Erectile Dysfunction in Northern Cameroon and Its Management
Journal of Cancer and Tumor International,
Due to the lack of hospitals with adequate technical platform on one hand, and high diagnostic costs that cannot be afforded most of the population, the incidence of prostate cancer in Cameroon has increased and has great impact on people’s health.
Aim: This work was undertaken with the objective to determine the impact of prostate cancer on erectile dysfunction and how to manage it.
Methodology: Sampling of the population was done in a comprehensive and non-probabilistic manner at the Urology Department of Ngaoundere Islamic Hospital, Ngaoundere, Cameroon, between June 2018 and November 2019. Of the 75 patients received, 50 of them participated in this study. Biopsies were taken from these patients to determine and confirm the form and stage of cancer followed by PSA assays. After the diagnosis was revealed, the testosterone assay was carried out in order to evaluate erectile functioning in the patients who equally completed a survey form made available to them in order to get an idea of their health history, the type of treatment followed and their lifestyle.
Results: The mean age of the patients was 67 years, with a predominance in the 60-70 age range. 85% of the patients had a Gleason score greater than or equal to 8. Of these patients, 42% had low testosterone levels (< 2.3 ng/mL), resulting to lack of morning erection (66.6%), loss of sexual desire (43.9%), difficulty having a spontaneous erection (88%). On the other hand, erectile dysfunction was revealed in the prostate cancer patients with low testosterone levels, with a history of hypertention (16.6%), diabetes (28.5%) alcohol consumption (44%), tobacco smoking (41%) and having undergone as prostate cancer treatment involving transurethral resection of the prostate (80%) and orchiectomy (20%).
Conclusion: The major cause of erectile dysfunction observed in patients suffering from prostate cancer in Northen Cameroon can be attributed to the evolution of the disease, as well as the health history of the patients (diabetes, hypertension).
- Prostate cancer
- testosterone level
- erectile dysfunction
- health history.
How to Cite
Kipanyula MJ, Seke Etet PF, Vecchio L, Farahna M, Nukenine EN, Nwabo Kamdje AH. Signaling pathways bridging microbial-triggered inflammation and cancer. Cell Signal. 2013;25(2):403-16.
Makarem N, Bandera EV, Lin Y, Jacques PF, Hayes RB, Parekh N. Carbohydrate nutrition and risk of adiposity-related cancers: results from the Framingham Offspring cohort (1991-2013). Br J Nutr. 2017;117(11):1603-14.
Nair-Shalliker V, Yap S, Nunez C, Egger S, Rodger J, Patel MI, et al. Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR). Int J Cancer. 2017;140(3):565-74.
Nwabo Kamdje AH, Takam Kamga P, Tagne Simo R, Vecchio L, Seke Etet PF, Muller JM, et al. Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog. Cancer Biol Med. 2017;14(2):109-20.
Seke Etet PF, Vecchio L, Nwabo Kamdje AH. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways? Cell Signal. 2012;24(7):1433-43.
Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. Conventional Treatments of Localized Prostate Cancer. Urology. 2008;72(6): S25-35.
Choo R, Long J, Gray R, Morton G, Gardner S, Danjoux C. Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function. Support Care Cancer. 2010;18(6):715-22.
Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med. 2016;375(15):1425-37.
Watson E, Shinkins B, Frith E, Neal D, Hamdy F, Walter F, et al. Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors: implications for redesigning follow-up. BJU International; 2015.
Pan F, Zhang J, Liu Y, Lu L, Qiu X, Lv K, et al. Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents. J Vis Exp. 2018;136.
Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer. 2002;95(8):1773-85.
Tindall DJ, Rittmaster RS. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer. J Urol. 2008;179(4):1235-42.
Lasselin J, Drouin SJ, Champy CM, Léon P, Casenave J, Cussenot O, et al. [Influence of plasmatic testosterone during natural history of prostate cancer: A review]. Prog Urol. 2013;23(7):438-43.
Tu H, Gu J, Meng QH, Kim J, Strom S, Davis JW, et al. Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer. Oncol Lett. Mars. 2017;13(3):1949-57.
Sirousbakht S, Rezakhaniha B. Effect of Colonoscopy on Prostate-Specific Antigen; New Words about an Old Subject. Int J Cancer Manag. 2018;11(7). Available:https://sites.kowsarpub.com/ijcm/articles/68919.html
Soheila Sirousbakht, and Bijan Rezakhaniha Effect of Colonoscopy on Prostate-Specific Antigen; New Words about an Old Subject. Int J Cancer Manag. 2018;11(7):e68919. DOI: 10.5812/ijcm.68919
Islami F, Moreira DM, Boffetta P, Freedland SJ. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol. 2014;66(6):1054-64.
Safavy S, Kilday PS, Slezak JM, Abdelsayed GA, Harrison TN, Jacobsen SJ, et al. Effect of a Smoking Cessation Program on Sexual Function Recovery Following Robotic Prostatectomy at Kaiser Permanente Southern California. Perm J. 2017;21:16-138.
Sighinolfi MC, Mofferdin A, De Stefani S, Micali S, Cicero AFG, Bianchi G. Immediate improvement in penile hemodynamics after cessation of smoking: Previous results. Urology. 2007;69(1):163-5.
Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson K-E, Althof S, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1(1):6-23.
Choi BR, Kim HK, Park JK. Penile Erection Induced by Scoparone from Artemisia capillaris through the Nitric Oxide-Cyclic Guanosine Monophosphate Signaling Pathway. World J Mens Health. 2017; 35(3):196-204.
Weinberg AE, Eisenberg M, Patel CJ, Chertow GM, Leppert JT. Diabetes Severity, Metabolic syndrome, and the risk of Erectile Dysfunction. J Sex Med. 2013; 10(12):3102-9.
Krajewski W, Halska U, Poletajew S, Piszczek R, Bieżyński B, Matyjasek M, et al. Influence of Transurethral Resection of Bladder Cancer on Sexual Function, Anxiety, and Depression. In: Pokorski M, éditeur. Clinical Medicine Research. Advances in Experimental Medicine and Biology. Cham: Springer International Publishing. 2018:37-50. Available:https://doi.org/10.1007/5584_2018_264
Abstract View: 627 times
PDF Download: 348 times